BSGCT Early Career Development and Collaboration Meeting 2019
BSGCT’s 2nd Early Career Development and Collaboration Meeting, took place in the afternoon of Friday 29th November. This free event…
Commercialising Academic Research: Risk and Opportunity
Author: Sam Goldsmith PhD, Senior Commercialisation of Research Manager, CGT Catapult. The Valley of Death is a well-known and steep…
Making gene and cell therapy possible: Viruses
So, we understand the problem. How do we fix it? Author: Alexander T. Baker, Senior Scientist, Accession Therapeutics Years of…
BSGCT Newsletter May 2022
The latest news and updates from the BSGCT Dear %FirstName%, There are a few announcements we would like to share…
In memory of Dr. Manfred Schmidt
In Memory Dr. Manfred Schmidt BSGCT would like to express our sadness and dismay at the loss of Dr. Manfred…
Researcher in the Spotlight: Alexandros Angelopoulos, Northumbria University
This month’s ‘researcher in the spotlight’ is BSGCT mentee, Alexandros Angelopoulos, Northumbria University. Can you tell us about your research…
BSGCT Newsletter March 2022
The latest news and updates from the BSGCT Dear %FirstName%, We are looking forward to welcoming Prof. Laurent Servais to…
Down but not out: how adenoviral vaccines may still save the day.
Authors: Prof Alan Parker, February 2022. In late 2019, the world could never have foreseen the impact that a new,…
An update on gene therapy for Spinal muscular atrophy
Author: Dr Rajvinder Karda, University College London, 16 December 2021 Rare disease is defined by the European Commission on Public…
First in man in vivo delivery of CRISPR-Cas9 targeting Transthyretin Amyloidosis
Authors: Dr Christos Georgiadis, October 2021. While this year has to most felt as though life came to a standstill,…
Vaccines for COVID-19
Author: Prof. Rafael J. Yáñez-Muñoz, Royal Holloway University of London, 30 August 2021 Vaccines are very much still a hot…
A Commentary on Vaccine-Induced Immune Thrombotic Thrombocytopenia
Authors: Miss Caitlin Dop and Dr Carly Bliss, May 2021. In response to the SARS-CoV-2 pandemic, a number of COVID-19…